EyeGate Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. -32.72%69.530.0%$388.91m
ICLRICON plc 1.11%243.272.8%$348.47m
VRXValeant Pharmaceuticals International, Inc. -1.18%29.2414.1%$172.05m
HZNPHorizon Therapeutics Plc -2.52%100.025.5%$112.77m
JAZZJazz Pharmaceuticals Plc -0.63%169.522.2%$84.19m
CTLTCatalent, Inc. 0.48%119.892.1%$76.78m
PRGOPerrigo Co. Plc 0.44%48.106.9%$48.96m
ENDPEndo International Plc 1.20%5.068.6%$46.03m
BHCBausch Health Cos., Inc. -1.18%29.240.0%$42.50m
ARGXargenx SE 2.90%304.430.0%$40.02m
UTHRUnited Therapeutics Corp. -1.24%181.9314.0%$39.35m
SAGESAGE Therapeutics, Inc. -0.91%43.737.6%$32.31m
NTECIntec Pharma Ltd. -16.68%11.290.0%$31.56m
IRWDIronwood Pharmaceuticals, Inc. 0.84%13.279.6%$25.32m
PLXPPLx Pharma, Inc. 0.21%18.730.1%$17.71m

Company Profile

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.